SK Life Science, Inc.
10 drugs in NADAC|0 Generic,10 Brand
SK Life Science, Inc. lists 10 NDCs in the CMS NADAC file (0 generic, 10 brand), at an average NADAC of $35.31 per unit, with a week-over-week move of +0.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
10
0G / 10B
Avg Price / Unit
$35.3084
$3.91 – $42.99
Avg 7d Change
+0.09%
Across 7 drugs with changes
7d Activity
of 10 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Frequently Asked Questions
How many drugs does SK Life Science, Inc. make?
SK Life Science, Inc. lists 10 NDCs in the CMS NADAC file — 0 generic and 10 brand products.
What is the average price of SK Life Science, Inc. drugs?
The average NADAC across SK Life Science, Inc.'s portfolio is $35.3084 per unit, ranging from $3.9104 to $42.9889.
Has SK Life Science, Inc. had any drug recalls?
No FDA enforcement recalls are matched to SK Life Science, Inc. in the openFDA feed.
How has SK Life Science, Inc.'s pricing changed recently?
Over the past 7 days, 6 SK Life Science, Inc. products rose and 1 fell, with a portfolio-wide average change of +0.1%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
XCOPRI 150-200 MG TITRATION PK cenobamate | $42.9889 per EA | +0.40% |
XCOPRI 50-100 MG TITRATION PAK cenobamate | $42.7640 per EA | +0.13% |
XCOPRI 350 MG DAILY DOSE PACK cenobamate | $42.6994 per EA | 0.00% |
XCOPRI 25 MG TABLET cenobamate | $39.8852 per EA | +0.03% |
XCOPRI 100 MG TABLET cenobamate | $39.8784 per EA | +0.04% |
XCOPRI 200 MG TABLET cenobamate | $39.8682 per EA | 0.00% |
XCOPRI 150 MG TABLET cenobamate | $39.8669 per EA | -0.03% |
XCOPRI 50 MG TABLET cenobamate | $39.8502 per EA | +0.04% |
XCOPRI 250 MG DAILY DOSE PACK cenobamate | $21.3729 per EA | 0.00% |
XCOPRI 12.5-25 MG TITRATION PK cenobamate | $3.9104 per EA | +0.02% |